Last $23.43 USD
Change Today -0.01 / -0.04%
Volume 278.9K
EBS On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 8:04 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Fuad El-Hibri

Founder, Executive Chairman and Chairman of Strategic Operations Committee, Emergent BioSolutions, Inc.
AgeTotal Calculated CompensationThis person is connected to 114 board members in 3 different organizations across 3 different industries.

See Board Relationships
56$1,295,472
As of Fiscal Year 2013

Background*

Mr. Fuad El-Hibri has been Chairman of the Board and Chief Executive Officer of Emergent Biodefense Operations Lansing Inc., a subsidiary of Emergent Biosolutions Inc. since June 2004. Mr. El-Hibri founded Emergent Biosolutions Inc. in 2004 and has been its Executive Chairman since June 2004. He served as Chief Executive Officer of Emergent Biosolutions Inc from June 2004 to April 01, 2012. He served as the President of Emergent BioSolutions, Inc. from March 2006 to ...

Read Full Background

Corporate Headquarters*

2273 Research Boulevard
Rockville, Maryland 20850

United States

Phone: 301-795-1800
Fax: 301-795-1899

Board Members Memberships*

Former Chairman
Director
Chairman and Chief Executive Officer
2004-Present
Founder, Executive Chairman and Chairman of Strategic Operations Committee

Education*

BA
The Leland Stanford Junior University
Master's Degree
Yale University

Other Affiliations*

Annual Compensation*

Salary$726,297
Total Annual Compensation$726,297

Stock Options*

Restricted Stock Awards$306,632
All Other Compensation$3,904
Exercisable Options290,021
Exercisable Options Value$1,649,800
Unexercisable Options89,942
Unexercisable Options Value$500,947
Total Value of Options$2,150,747
Total Number of Options379,963

Total Compensation*

Total Annual Cash Compensation$730,201
Total Short Term Compensation$726,297
Other Long Term Compensation$310,536
Total Calculated Compensation$1,295,472
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EBS:US $23.43 USD -0.01

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
William S. Marth Chief Executive Officer, President, Director and Member of Audit Committee
Albany Molecular Research Inc.
--
Peter William Grant Chief Executive Officer and Executive Director
SkyePharma plc
567.0K GBP
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$340.0K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMERGENT BIOSOLUTIONS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.